Changes to telemedicine coverage for Medicare patients

Effective October 1, 2025, the telemedicine flexibilities for patients of Medicare, Medicare Advantage, Medicaid, and TRICARE programs have expired. For patients insured by these plans, this impacts any upcoming virtual visits with your healthcare provider. 

tPA is a powerful and effective clot-dissolving drug administered during a minimally invasive treatment to treat stroke. tPA is often administered in an emergency setting to minimize the serious, often life-threatening effects of a blocked blood vessel.

The interventional physician threads a catheter up to the site of the blockage in the brain, a procedure known as intra-arterial thrombolysis. The physician then delivers the powerful thrombolytic drug tissue plasminogen activator (tPA) – often called the "clot buster" for its ability to dissolve blockages in blood vessels and restore blood flow in the brain.

Deploying the drug at the site of the clot rather than through the blood stream allows for the most effective result, and it can be effective up to six hours after the onset of stroke symptoms (depending on the clot's location). In addition, the interventionist can monitor the treatment's effectiveness from within the blood vessel itself, allowing for more detailed information.

Related information: 
Learn About stroke

 

tPA is a treatment for stroke, often administered in an emergency setting when early treatment can make the biggest difference for a positive outcome.